Clinical Trial News and Research

RSS
TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

Inovio first quarter total revenue increases to $3.1 million for 2011

Inovio first quarter total revenue increases to $3.1 million for 2011

Women with invasive breast cancer can benefit from new genomic test

Women with invasive breast cancer can benefit from new genomic test

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer

Novel ultrasound-targeted microbubble-destruction technology advances cure for prostate cancer

16-year-old uses supercomputing network to invent new drug cocktail for cystic fibrosis

16-year-old uses supercomputing network to invent new drug cocktail for cystic fibrosis

New drug targets bile acid to provide relief from constipation

New drug targets bile acid to provide relief from constipation

Micromet first quarter total revenues decrease to $5.5 million

Micromet first quarter total revenues decrease to $5.5 million

Insmed first quarter revenues decrease to $1.6 million

Insmed first quarter revenues decrease to $1.6 million

Inspire reports net loss of $17.6 million for first quarter 2011

Inspire reports net loss of $17.6 million for first quarter 2011

CorMedix first quarter net loss decreases to $1.9 million

CorMedix first quarter net loss decreases to $1.9 million

EpiCept first quarter net loss decreases to $2.5 million

EpiCept first quarter net loss decreases to $2.5 million

Successful treatment of depression in mothers improves behavior of children

Successful treatment of depression in mothers improves behavior of children

OncoGenex first quarter revenue decreases to $1.2 million

OncoGenex first quarter revenue decreases to $1.2 million

Nexvax2- coeliac disease vaccine shows promising results in Phase I clinical trial

Nexvax2- coeliac disease vaccine shows promising results in Phase I clinical trial

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

UCSF scientists receive CIRM grants to advance degenerative muscle disease research

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Teen alcohol consumption associated with computer use

Teen alcohol consumption associated with computer use

Uganda: First vaccination for GMZ2 malaria vaccine trial

Uganda: First vaccination for GMZ2 malaria vaccine trial

Novavax first quarter net loss decreases to $7.5 million

Novavax first quarter net loss decreases to $7.5 million

ImThera Medical concludes Phase I and II protocols for aura6000 European Pilot study in OSA

ImThera Medical concludes Phase I and II protocols for aura6000 European Pilot study in OSA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.